BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 38528272)

  • 1. Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC-MS/MS.
    Dai S; Zhu J; Chen X; Zheng L; Li X; Liu L
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):157. PubMed ID: 38528272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and diagnostic value of serum bile acids profile in pregnant women with intrahepatic cholestasis of pregnancy and asymptomatic hypercholanemia of pregnancy].
    Gou LS; Yin X; Liu J; Suo F; Wu XY; Wang ZZ; Wang QL; Dong BL; Gu MS; Liu DY
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):270-278. PubMed ID: 38644273
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of bile acid spectrum in the evaluation of hepatic injury in children with infectious mononucleosis caused by Epstein Barr virus infection.
    Shen R; Zhou Y; Zhang L; Yang S
    Front Pediatr; 2023; 11():1109762. PubMed ID: 37025296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal bile acid profile and subtype analysis of intrahepatic cholestasis of pregnancy.
    Shao Y; Chen S; Li H; Tang Q; Xu D
    Orphanet J Rare Dis; 2021 Jun; 16(1):259. PubMed ID: 34098996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
    Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile Acid Metabolome after an Oral Lipid Tolerance Test by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Schmid A; Neumann H; Karrasch T; Liebisch G; Schäffler A
    PLoS One; 2016; 11(2):e0148869. PubMed ID: 26863103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of HMGB1 in hepatocytes accelerates PTEN inactivation-induced liver cancer.
    Athavale D; Barahona I; Song Z; Desert R; Chen W; Han H; Das S; Ge X; Komakula SSB; Gao S; Lantvit D; Guzman G; Nieto N
    Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids promote the development of HCC by activating inflammasome.
    Chen W; Ding M; Ji L; Yao J; Guo Y; Yan W; Yu S; Shen Q; Huang M; Zheng Y; Lin Y; Wang Y; Liu Z; Lu L; Jin X
    Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37556375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer.
    Wang J; Xu H; Wang Y; Feng L; Yi F
    Can J Gastroenterol Hepatol; 2023; 2023():5492931. PubMed ID: 37153689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review).
    Kuang G; Wang Z; Luo C; Luo J; Wang J
    Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36367187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to Static Magnetic and Electric Fields Treats Type 2 Diabetes.
    Carter CS; Huang SC; Searby CC; Cassaidy B; Miller MJ; Grzesik WJ; Piorczynski TB; Pak TK; Walsh SA; Acevedo M; Zhang Q; Mapuskar KA; Milne GL; Hinton AO; Guo DF; Weiss R; Bradberry K; Taylor EB; Rauckhorst AJ; Dick DW; Akurathi V; Falls-Hubert KC; Wagner BA; Carter WA; Wang K; Norris AW; Rahmouni K; Buettner GR; Hansen JM; Spitz DR; Abel ED; Sheffield VC
    Cell Metab; 2022 Nov; 34(11):1893. PubMed ID: 36323238
    [No Abstract]   [Full Text] [Related]  

  • 12. Bile acids and the gut microbiota: metabolic interactions and impacts on disease.
    Collins SL; Stine JG; Bisanz JE; Okafor CD; Patterson AD
    Nat Rev Microbiol; 2023 Apr; 21(4):236-247. PubMed ID: 36253479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acids as drivers and biomarkers of hepatocellular carcinoma.
    Colosimo S; Tomlinson JW
    World J Hepatol; 2022 Sep; 14(9):1730-1738. PubMed ID: 36185719
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.